Sponsored By

Invibio Knee Ltd., a subsidiary of Invibio Biomaterials Solutions (Thornton Cleveleys, UK), has partnered with Maxx Orthopedics Inc. (Plymouth Meeting, PA) to develop a PEEK-Optima femoral knee replacement. The technology is being developed to address some of the unmet needs of more than a half-million patients annually who are dissatisfied with the outcome following total knee arthroplasty using metal-based knee solutions, according to Invibio. An international multi-center pre-market clinical trial is currently in planning to evaluate the new technology.

PlasticsToday Staff

February 25, 2016

1 Min Read
Invibio partners with orthopedics company to develop PEEK-based knee-replacement device


Freedom Total Knee system. Photo
courtesy Maxx Orthopedics.

Invibio Biomaterial Solutions has been evangelizing for PEEK-Optima–based medical device solutions for more than 15 years, supporting device companies around the world with innovations as well as manufacturing and in-depth knowledge to advance the medical device market. Spinal implants based on biocompatible PEEK-Optima polymers are now widely recognized and are used frequently within the spinal fusion market, notes Invibio. Its materials are used in more than five million implanted devices worldwide.

Maxx Orthopedics designs, develops and supplies joint replacement products such as its flagship product, the Freedom Total Knee System (pictured), which has received 510(k) clearance from FDA. Launched in 2009, the Freedom Knee recently completed more than 25,000 successful implantations worldwide.

Sign up for the PlasticsToday NewsFeed newsletter.

You May Also Like